Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1999-12-10
pubmed:abstractText
alpha2-Adrenoceptors (alpha2-AR) modulate many central nervous system functions, such as regulation of sympathetic tone, vigilance, attention, and reactivity to environmental stressors. Three alpha2-AR subtypes (alpha2A, alpha2B, and alpha2C) with distinct tissue-distribution patterns are known to exist, but the functional significance of each subtype is not clear. Since specific, alpha2-AR subtype-selective pharmacological probes are not available, mice with genetically altered alpha2C-AR expression were studied in order to investigate the possible involvement of the alpha2C-AR in physiological and behavioral responses to acute and repeated stress. A modified version of Porsolt's forced swimming test was used to assess the possible effects of altered alpha2C-AR expression on the development of behavioral despair. alpha2C-Overexpression increased and the lack of alpha2C-AR (alpha2C-KO) decreased the immobility of mice in the forced swimming test, ie alpha2C-AR expression appeared to promote the development of behavioral despair. In addition, alpha2C-KO was associated with attenuated elevation of plasma corticosterone after different stressors, and overexpression of alpha2C-ARs was linked with increased corticosterone levels after repeated stress. Moreover, the brain dopamine and serotonin balance, but not norepinephrine turnover, was dependent on alpha2C-AR expression, and the expression of c-fos and junB mRNA was increased in alpha2C-KO mice. Since alpha2C-KO produced stress-protective effects, and alpha2C-AR overexpression seemed to promote the development of changes related to depression, it is suggested that a yet-to-be developed subtype-selective alpha2C-AR antagonist might have therapeutic value in the treatment of stress-related neuropsychiatric disorders.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/3,4-Dihydroxyphenylacetic Acid, http://linkedlifedata.com/resource/pubmed/chemical/Corticosterone, http://linkedlifedata.com/resource/pubmed/chemical/Genetic Markers, http://linkedlifedata.com/resource/pubmed/chemical/Homovanillic Acid, http://linkedlifedata.com/resource/pubmed/chemical/Hydroxyindoleacetic Acid, http://linkedlifedata.com/resource/pubmed/chemical/Methoxyhydroxyphenylglycol, http://linkedlifedata.com/resource/pubmed/chemical/Norepinephrine, http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-fos, http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-jun, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Adrenergic, alpha-2, http://linkedlifedata.com/resource/pubmed/chemical/Serotonin
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1359-4184
pubmed:author
pubmed:issnType
Print
pubmed:volume
4
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
443-52
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:10523817-3,4-Dihydroxyphenylacetic Acid, pubmed-meshheading:10523817-Animals, pubmed-meshheading:10523817-Behavior, Animal, pubmed-meshheading:10523817-Cerebral Cortex, pubmed-meshheading:10523817-Corpus Striatum, pubmed-meshheading:10523817-Corticosterone, pubmed-meshheading:10523817-Depression, pubmed-meshheading:10523817-Dopamine, pubmed-meshheading:10523817-Genes, Immediate-Early, pubmed-meshheading:10523817-Genetic Markers, pubmed-meshheading:10523817-Hippocampus, pubmed-meshheading:10523817-Homovanillic Acid, pubmed-meshheading:10523817-Hydroxyindoleacetic Acid, pubmed-meshheading:10523817-In Situ Hybridization, pubmed-meshheading:10523817-Methoxyhydroxyphenylglycol, pubmed-meshheading:10523817-Mice, pubmed-meshheading:10523817-Mice, Transgenic, pubmed-meshheading:10523817-Norepinephrine, pubmed-meshheading:10523817-Proto-Oncogene Proteins c-fos, pubmed-meshheading:10523817-Proto-Oncogene Proteins c-jun, pubmed-meshheading:10523817-RNA, Messenger, pubmed-meshheading:10523817-Receptors, Adrenergic, alpha-2, pubmed-meshheading:10523817-Restraint, Physical, pubmed-meshheading:10523817-Serotonin, pubmed-meshheading:10523817-Stress, Physiological, pubmed-meshheading:10523817-Swimming
pubmed:year
1999
pubmed:articleTitle
Genetic alteration of the alpha2-adrenoceptor subtype c in mice affects the development of behavioral despair and stress-induced increases in plasma corticosterone levels.
pubmed:affiliation
Orion Corporation, Orion Pharma, FIN-20101 Turku, Finland.
pubmed:publicationType
Journal Article